• Congratulations to Shapla Bhattacharya, PhD student in the Biotechnology group, on winning the best poster award at the EMBO practical school on 'High throughput protein production and crystallization' held in Marseille, France (4-12 July 2022). Congratulations, Shapla!!

  • Participation of the Biotechnology group in the FEBS3+ Conference of  Estonian, Latvian and Lithuanian Biochemical Societies, organized by the Estonian Biochemical Society, Tallinn, Estonia   | 15 – 17 June 2022.

    Oral presentations by: Dr. Emilio Parisini (Principal Investigator, Head of the Biotechnology group) “Drugging the undruggable: towards the development of selective modulators of cadherin-mediated cell-cell adhesion” and Dr. Teodors Pantelejevs (Researcher) “A conserved mechanism of interferon signalling antagonism in poxviruses and paramyxoviruses”.

  • BSc student Linda Legzdina graduated on 06/06/2022 in the Faculty of Biology of the University of Latvia discussing a thesis titled: “Towards the design of engineered enzymes for protein deglycation” (Mark: 9) (Supervisor: Dr. Emilio Parisini). Congratulations, Linda!!

  • Participation in the awarded COST action CA21111 (2022-2026) – OneHealthdrugs – “One health drugs against parasitic vector borne diseases in Europe and beyond”. Dr. Parisini has been nominated LIOS representative in the Managing Committee for this international collaborative grant.

  • Dr. Emilio Parisini has been invited to deliver a lecture at the XXII Edoardo Amaldi Conference 'Nuclear Risks and Arms Control: Problems and Progress in the Time of Pandemics and War', which was held at the Accademia dei Lincei in Rome (Italy) on 6-8 Apr. 2022. Title of Dr. Parisini's oral presentation: 'International cooperation to tackle future pandemics'.

  • Dr. Emilio Parisini has been elected as the Latvia representative in the Scientific Committee of the European Society of Applied Biocatalysis (ESAB) (24 March 2022)

  • Dr. Parisini has completed a 4-month Visiting Professorship at the Politecnico di Milano (Italy, Oct 2021-Jan 2022).

  • Dr. Parisini has secured a Latvia-French bilateral grant (OSMOSIS) in collaboration with Prof. Frederic Andre' (CNRS-Marseille).

  • Great news

    The BioDrug webpage is LIVE now!